As a novel tumor suppressor, SPTBN1 expression is dysregulated in hepatocellular carcinoma [20–22], pancreatic cancer [23, 24], colorectal cancer [25], ovarian cancer [26] and lung cancer [27]. This evidence concerns the gene SPTBN1 and neoplasm.